Shanghai, China

Chuanlong Tang

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chuanlong Tang: Innovator in Protein Expression Technology

Introduction

Chuanlong Tang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in enhancing protein expression systems. His innovative work has led to the development of a unique transcriptional regulatory element that has practical applications in various biotechnological processes.

Latest Patents

Chuanlong Tang holds a patent for a transcriptional regulatory element and its use in enhancing the expression of heterologous proteins. This patent describes a polynucleotide that serves as a WXRE transcriptional regulatory element, which can significantly increase the protein expression level in a protein expression system. The invention also includes a protein expression vector or system that incorporates this WXRE element, allowing for enhanced expression levels of heterologous proteins while maintaining their biological activity.

Career Highlights

Throughout his career, Chuanlong Tang has worked with prominent companies in the biotechnology sector, including Wuxi Biologics Ireland Limited and Wuxi Biologics Ireland Limited. His experience in these organizations has allowed him to apply his innovative ideas in real-world applications, contributing to advancements in protein expression technologies.

Collaborations

Chuanlong Tang has collaborated with several professionals in his field, including Zheng Zhang and Xiaolu Li. These collaborations have fostered a productive environment for innovation and research, leading to significant advancements in biotechnology.

Conclusion

Chuanlong Tang's contributions to the field of protein expression technology highlight his role as an influential inventor. His patented work and collaborations demonstrate his commitment to advancing biotechnological applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…